ArticleFrontiers in oncology2023

JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China.

Mengting Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.